The combined market valuation of nine of the top-10 most valued firms slumped by Rs 2.51 lakh crore last week, with Reliance Industries taking the biggest hit, in line with a weak trend in equities.Read More
Axis Bank is expected to post a mixed Q3 performance, with healthy loan and deposit growth supporting balance sheet expansion, but pressure on margins weighing on profitability. Brokerages see NII rising about 4% year-on-year, while PAT is likely to decline around 8%. Loan growth is seen rebounding to about 14% YoY, with deposits growing faster...Read More
The US Federal Reserve is widely expected to keep interest rates unchanged when it meets in the coming week, holding firm despite President Donald Trump’s pressure to slash levels as it guards against threats to its independence. – External pressure – The Fed meets eight times a year to consider interest rate levels, and Michael...Read More
Based on consensus estimates, Trendlyne data shows that a number of midcap stocks are poised to deliver strong returns over the next 12 months.Read More
According to VK Vijayakumar, Chief Investment Strategist at Geojit Financial Services, FPIs not only continued their selling spree in the week ended January 23 but also intensified it. The sustained outflows have wiped off Rs 16 trillion in market capitalisation for the week alone, contributing to a 2.5% decline in the Nifty index.Read More
Markets experienced a sharp corrective move, with Nifty ending lower after a volatile week and breaking below key technical levels. India VIX surged, signaling increased risk perception. Despite a potential technical rebound due to oversold conditions, volatility is expected to remain elevated, especially with F&O expiry.Read More
Adani Group companies clarified via stock exchange filings that they are not parties to any US SEC legal proceedings. Reports indicated the SEC sought court approval to serve summons to Gautam Adani and Sagar Adani via email after Indian authorities denied previous requests. The group reiterated no allegations are against the company.Read More
Mala Gaonkar’s SurgoCap Partners experienced a rapid ascent, tripling its assets to $6 billion within three years of its 2023 launch. This marked one of the fastest-growing debuts in hedge fund history, with Gaonkar leveraging data science to invest across various sectors. She emphasizes a small, collaborative team size for idea generation, drawing parallels to...Read More
Despite the decline in overall portfolio value during FY26, stock-level performance remains encouraging. More than half of the holdings delivered positive returns, with 11 stocks surging between 25% and 90% within a span of less than 10 months in FY26.Read More
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.